Radoslaw Zagożdżon (Radosław Zagożdżon, Radoslaw Zagozdzon)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 45

Top Venues

Cancer immunology, immunotherapy : CII

International journal of molecular sciences

Cells

Cancers

Medical University of Warsaw

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Warsaw Jan 01 2017

Poland

Head of the Department :: Department of Clinical Immunology

Publications

Katarzyna Zielniok, Kinga Rusinek, Anna Słysz, Mieszko Lachota, Ewa Bączyńska, Natalia Krata, Anna Szpakowska, Martyna Ciepielak, Bartosz Foroncewicz, Krzysztof Mucha, Radoslaw Zagożdżon, Zygmunt Pojda
3D-Bioprinted Co-Cultures of Glioblastoma Multiforme and Mesenchymal Stromal Cells Indicate a Role for Perivascular Niche Cells in Shaping Glioma Chemokine Microenvironment. Cells 13 (17) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, Radoslaw Zagożdżon, Beata Kaleta
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. Cells 13 (1) (2024)
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, Radoslaw Zagożdżon, Beata Kaleta
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. Cells 13 (1) (2024)
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, Radoslaw Zagożdżon, Beata Kaleta
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. Cells 13 (1) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Michał Zych, Monika Kniotek, Aleksander Roszczyk, Filip Andrzej Dąbrowski, Robert Jędra, Radoslaw Zagożdżon
Surface Immune Checkpoints as Potential Biomarkers in Physiological Pregnancy and Recurrent Pregnancy Loss. International journal of molecular sciences 25 (17) (2024)
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, Radoslaw Zagożdżon, Beata Kaleta
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. Cells 13 (1) (2024)
Michał Zych, Aleksander Roszczyk, Filip Andrzej Dąbrowski, Monika Kniotek, Radoslaw Zagożdżon
Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss-A Preliminary Study. International journal of molecular sciences 25 (1) (2023)
Michał Zych, Aleksander Roszczyk, Filip Andrzej Dąbrowski, Monika Kniotek, Radoslaw Zagożdżon
Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss-A Preliminary Study. International journal of molecular sciences 25 (1) (2023)
Małgorzata Kałucka, Aleksander Roszczyk, Marzenna Klimaszewska, Beata Kaleta, Ewelina Drelich, Anna Błażewicz, Sandra Górska, Eliza Malinowska, Marek Król, Aleksandra Maria Prus, Katarzyna Trześniowska, Aleksandra Wołczyńska, Przemysław Dorożyński, Radoslaw Zagożdżon, Jadwiga Turło
Optimization of Se- and Zn-Enriched Mycelium of Lentinula edodes (Berk.) Pegler as a Dietary Supplement with Immunostimulatory Activity. Nutrients 15 (18) (2023)
Marta Śledź, Alicja Wojciechowska, Radoslaw Zagożdżon, Beata Kaleta
Correction to: In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy. Archivum immunologiae et therapiae experimentalis 71 (1) (2023)
Michał Zych, Aleksander Roszczyk, Filip Andrzej Dąbrowski, Monika Kniotek, Radoslaw Zagożdżon
Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss-A Preliminary Study. International journal of molecular sciences 25 (1) (2023)
Marta Śledź, Alicja Wojciechowska, Radoslaw Zagożdżon, Beata Kaleta
In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy. Archivum immunologiae et therapiae experimentalis 71 (1) (2023)
Aleksander Roszczyk, Michał Zych, Katarzyna Zielniok, Natalia Krata, Jadwiga Turło, Marzenna Klimaszewska, Radoslaw Zagożdżon, Beata Kaleta
The Effect of Novel Selenopolysaccharide Isolated from Lentinula edodes Mycelium on Human T Lymphocytes Activation, Proliferation, and Cytokines Synthesis. Biomolecules 12 (12) (2022)
Radoslaw Zagożdżon, Magdalena Winiarska, Malgorzata Firczuk
Immune Evasion as the Main Challenge for Immunotherapy of Cancer. Cancers 14 (15) (2022)
Aleksander Roszczyk, Jadwiga Turło, Radoslaw Zagożdżon, Beata Kaleta
Immunomodulatory Properties of Polysaccharides from Lentinula edodes . International journal of molecular sciences 23 (16) (2022)
Rafał Staros, Agata Michalak, Kinga Rusinek, Krzysztof Mucha, Zygmunt Pojda, Radoslaw Zagożdżon
Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion. Cancers 14 (13) (2022)
Aleksander Roszczyk, Michał Zych, Katarzyna Zielniok, Natalia Krata, Jadwiga Turło, Marzenna Klimaszewska, Radoslaw Zagożdżon, Beata Kaleta
The Effect of Novel Selenopolysaccharide Isolated from Lentinula edodes Mycelium on Human T Lymphocytes Activation, Proliferation, and Cytokines Synthesis. Biomolecules 12 (12) (2022)
Aleksander Roszczyk, Michał Zych, Katarzyna Zielniok, Natalia Krata, Jadwiga Turło, Marzenna Klimaszewska, Radoslaw Zagożdżon, Beata Kaleta
The Effect of Novel Selenopolysaccharide Isolated from Lentinula edodes Mycelium on Human T Lymphocytes Activation, Proliferation, and Cytokines Synthesis. Biomolecules 12 (12) (2022)
Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Anna Burdzinska, Angelika Muchowicz, Agnieszka Goral, Andriy Zhylko, Karolina Soroczynska, Kuba Retecki, Marta Krawczyk, Marta Klopotowska, Zofia Pilch, Leszek Paczek, Karl-Johan Malmberg, Sébastien Wälchli, Magdalena Winiarska, Radoslaw Zagożdżon
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells. Journal for immunotherapy of cancer 10 (1) (2022)
Aleksander Roszczyk, Michał Zych, Katarzyna Zielniok, Natalia Krata, Jadwiga Turło, Marzenna Klimaszewska, Radoslaw Zagożdżon, Beata Kaleta
The Effect of Novel Selenopolysaccharide Isolated from Lentinula edodes Mycelium on Human T Lymphocytes Activation, Proliferation, and Cytokines Synthesis. Biomolecules 12 (12) (2022)
Beata Kaleta, Aleksander Roszczyk, Michał Zych, Monika Kniotek, Radoslaw Zagożdżon, Marzenna Klimaszewska, Eliza Malinowska, Michał Pac, Jadwiga Turło
Selective Biological Effects of Selenium-Enriched Polysaccharide (Se-Le-30) Isolated from Lentinula edodes Mycelium on Human Immune Cells. Biomolecules 11 (12) (2021)
Jolanta Zegarska, Ewa Więsik-Szewczyk, Ewa Hryniewiecka, Beata Wolska-Kusnierz, Dariusz Soldacki, Magdalena Kacprzak, Agnieszka Sobczynska-Tomaszewska, Kamila Czerska, Pawel Siedlecki, Karina Jahnz-Rozyk, Ewa Bernatowska, Radoslaw Zagożdżon, Leszek Pączek
Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) with a New Pathogenic Variant in TNFRSF1A Gene in a Family of the Adult Male with Renal AA Amyloidosis-Diagnostic and Therapeutic Challenge for Clinicians. Journal of clinical medicine 10 (3) (2021)
Monika Kniotek, Aleksander Roszczyk, Michał Zych, Małgorzata Wrzosek, Monika Szafarowska, Radoslaw Zagożdżon, Małgorzata Maria Jerzak
Sildenafil Citrate Downregulates PDE5A mRNA Expression in Women with Recurrent Pregnancy Loss without Altering Angiogenic Factors-A Preliminary Study. Journal of clinical medicine 10 (21) (2021)
Sandra Górska, Marzenna Klimaszewska, Piotr Podsadni, Beata Kaleta, Radoslaw Zagożdżon, Sabina Górska, Andrzej Gamian, Tomasz Strączek, Czesław Kapusta, Marcin Janusz Cieślak, Julia Kaźmierczak-Barańska, Barbara Nawrot, Jadwiga Turło
Selenium-Containing Exopolysaccharides Isolated from the Culture Medium of Lentinula edodes: Structure and Biological Activity. International journal of molecular sciences 22 (23) (2021)
Michał Zych, Aleksander Roszczyk, Monika Kniotek, Filip Dąbrowski, Radoslaw Zagożdżon
Differences in Immune Checkpoints Expression (TIM-3 and PD-1) on T Cells in Women with Recurrent Miscarriages-Preliminary Studies. Journal of clinical medicine 10 (18) (2021)
Marzenna Klimaszewska, Sabina Górska, Grzegorz Lapienis, Beata Kaleta, Sandra Górska, Marta Kaszowska, Maciej Dawidowski, Andrzej Gamian, Radoslaw Zagożdżon, Andrzej Górski, Jadwiga Turło
Identification of the Primary Structure of Selenium-Containing Polysaccharides Selectively Inhibiting T-Cell Proliferation. Molecules (Basel, Switzerland) 26 (17) (2021)
Natalia Krata, Bartosz Foroncewicz, Radoslaw Zagożdżon, Barbara Moszczuk, Magdalena Zielenkiewicz, Leszek Pączek, Krzysztof Mucha
Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis. Archivum immunologiae et therapiae experimentalis 70 (1) (2021)
Katarzyna Zielniok, Anna Burdzinska, Victor Murcia Pienkowski, Agnieszka Koppolu, Malgorzata Rydzanicz, Radoslaw Zagożdżon, Leszek Pączek
Gene Expression Profile of Human Mesenchymal Stromal Cells Exposed to Hypoxic and Pseudohypoxic Preconditioning-An Analysis by RNA Sequencing. International journal of molecular sciences 22 (15) (2021)
Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Malgorzata Kurkowiak, Arman Rahman, Claudia Aura, Niamh Russell, Agata O Zych, Malgorzata Firczuk, Magdalena Winiarska, William M Gallagher, Radoslaw Zagożdżon
Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells. Antioxidants (Basel, Switzerland) 9 (4) (2020)
Katarzyna Zielniok, Anna Burdzinska, Beata Kaleta, Radoslaw Zagożdżon, Leszek Pączek
Vadadustat, a HIF Prolyl Hydroxylase Inhibitor, Improves Immunomodulatory Properties of Human Mesenchymal Stromal Cells. Cells 9 (11) (2020)
Mieszko Lachota, Marianna Vincenti, Magdalena Winiarska, Kjetil Boye, Radoslaw Zagożdżon, Karl-Johan Malmberg
Prospects for NK Cell Therapy of Sarcoma. Cancers 12 (12) (2020)
Malgorzata Bobrowicz, Radoslaw Zagożdżon, Joanna Domagala, Roberta Vasconcelos-Berg, Emmanuella Guenova, Magdalena Winiarska
Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives. Cancers 11 (10) (2019)
Katsiaryna Marhelava, Zofia Pilch, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Radoslaw Zagożdżon
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer. Cancers 11 (11) (2019)
Michał Zych, Aleksander Roszczyk, Monika Kniotek, Beata Kaleta, Radoslaw Zagożdżon
Sildenafil Citrate Influences Production of TNF-α in Healthy Men Lymphocytes. Journal of immunology research 2019 (2019)
Agata O Zych, Malgorzata Bajor, Radoslaw Zagożdżon
Application of Genome Editing Techniques in Immunology. Archivum immunologiae et therapiae experimentalis 66 (4) (2018)

Radoslaw Zagożdżon.css-eqlu8i{font-size:small;padding-left:4px;} (Radosław Zagożdżon, Radoslaw Zagozdzon)

Publication Activity (10 Years)

Top Topics

Top Venues

Radoslaw Zagożdżon (Radosław Zagożdżon, Radoslaw Zagozdzon)